Make us preferred on Google

Summer COVID surge: Cases rise again across US amid mounting wave

Experts stated overall infection levels remain relatively low in contrast to the previous waves

Summer COVID surge: Cases rise again across US amid mounting wave
Summer COVID surge: Cases rise again across US amid mounting wave

COVID-19 cases are significantly increasing again across the USA, with health experts issuing a warning that the country is facing another summer surge.

The raise is being reported in the US, with the virus being spread most in the South and West. Cases continue to increase in the Midwest and Northeast.

However, experts stated overall infection levels remain relatively low in contrast to the previous waves.


Summer surge seems milder

Dr. John Brooks, an infectious disease specialist at Emory University, said COVID-19 is “ticking up pretty much everywhere” nationally.

The good news is that this summer’s wave is seemingly following a trend seen in recent years, with some people contracting the disease, becoming ill and getting admitted in the hospitals.

Experts believe growing immunity from previous infections and vaccinations may be assisting to reduce the severity of the disease.

Still, COVID-19 can cause significant illness, with some people experiencing symptoms for one or two weeks. It may lead to missed work, school and travel plans.

Who remains most at risk?

Older adults, infants and immunosuppressed people remain particularly vulnerable to severe COVID-19, as per epidemiologist Caitlin Rivers of Johns Hopkins University.

Unlike influenza that usually peaks during winter, COVID-19 has developed seasonal waves during both winter and summer. Researchers are still unable to comprehend the pattern of the virus.

Vaccines and new treatment

Experts continue to encourage individuals to stay updated with COVID-19 vaccinations. The next updated vaccines are likely to become accessible soon and are particularly designed to target the dominant circulating strain.

Meanwhile, medical groups continue to advise vaccination despite changes in federal guidance.

A new drug called Xocova is also available for people after exposure to COVID-19 and may help reduce the chance of developing illness.